Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-273236
Filing Date
2025-11-10
Accepted
2025-11-10 07:10:45
Documents
68
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q olma-20250930.htm   iXBRL 10-Q 3220168
2 EX-31.1 olma-ex31_1.htm EX-31.1 16907
3 EX-31.2 olma-ex31_2.htm EX-31.2 16902
4 EX-32.1 olma-ex32_1.htm EX-32.1 14535
  Complete submission text file 0001193125-25-273236.txt   10249397

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20250930.xsd EX-101.SCH 970070
71 EXTRACTED XBRL INSTANCE DOCUMENT olma-20250930_htm.xml XML 1988801
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 251464306
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)